Abstract
Aim:
To investigate the possible correlation of nucleophosmin/B23 expression with bladder carcinoma recurrence.
Methods:
Surgically-resected bladder tumors staged pTa to pT4 were examined for nucleophosmin/B23 expression by immuno-histochemistry. The study group consisted of 132 consecutive patients surgically treated at Chang Gung Memorial Hospital between December 1998 and November 1999. The mean follow up was 72 months (range: 48-84 months).
Results:
Nuclear nucleophosmin/B23 staining was detected in 96% of advanced stage and poorly-differentiated tumors. Higher nucleophosmin/B23 levels were linked to more advanced tumor stages, grades, poor prognosis, and likelihood of recurrence (P<0.05). The Cox multivariate analysis indicated the nucleophosmin/B23 expression as an independent indicator for tumor recurrence (P=0.009).
Conclusion:
The results suggest that nucleophosmin/B23 is a favorable prognostic indicator for bladder cancer. Nucleophosmin/B23 could be a useful molecular tumor marker for predicting bladder cancer recurrence.
Similar content being viewed by others
Article PDF
References
Partin DM, Bray F, Ferlay J, Pisani P . Global cancer statistics. CA Cancer J Clin 2005; 55: 74–108.
Heney N, Ahmed S, Flanagan MJ, Frable W, Corder MP, Hafermann MD, et al. Superficial bladder: progression and recurrence. J Urol 1983; 130: 1983–6.
Hsu ZY, Yung BYM . Down-regulation of nucleophosmin/B23 during retinoic acid-induced differentiation of human promyelocytic leukemia HL-60 cells. Oncogene 1998; 16: 915–23.
Liu WH, Yung BYM . Mortalization of human promyelocytic leukemia HL-60 cells to be more susceptible to sodium butyrate-induced apoptosis and inhibition of telomerase activity by down-regulation of nucleophosmin/B23. Oncogene 1998; 17: 3055–64.
Feuerstein N, Spiegel S, Mond JJ . The nuclear matrix protein, numatrin (B23), is associated with growth factor induced mitogenesis in Swiss 3T3 fbroblasts and with T lymphocyte proliferation stimulated by lectins and anti-T cell antigen receptor antibody. J Cell Biol 1988; 107: 1629–42.
Tsui KH, Cheng AJ, Chang PL, Pan TL, Yung BYM . Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma. Urology 2004; 64: 839–44.
Sobin LH, Wittekind CH . Urinary bladder. In Sobin LH, editor. TNM classification of malignancy tumors, v5. 5th ed. New York: Wiley—Liss; 1977. p 187–9.
Mostofi FK, Sobin LH, Torloni H . Histological typing of urinary bladder tumors. In: Mostof FK, editor. International classification of tumors, No. 10. Geneva: World Health Organization, 1973.
Suash S, Mehar CS, Deepak KG, Chitra S . Angiogenic patterns and their quantitation in high grade astrocytic tumors. J Neurooncol 2006; 79: 19–30.
Raghaven D, Shipley WU, Garnick MB, Rusell PJ, Richie JP . Biology and management of bladder cancer. N Engl J Med 1990; 322: 1129–38.
Ramakumar S, Bhuiyan J, Besse JA, Rusell PJ, Richie JP . Comparison of screening methods in the detection of bladder cancer. J Urol 1999; 161: 388–94.
Tsui KH, Chen SM, Wang TM, Juang HH, Chen CL, Sun GH, et al. Comparison of voided urine cytology, nuclear matrix protein-22 and bladder tumor associated antigen tests for bladder cancer of geriatric male patients in Taiwan, China. Asian J Androl 2007; 9: 711–5.
Tada Y, Wada M, Taguchi K, Mochida Y, Kinugawa N, Tsuneyoshi M . The association of death-associated protein kinase hypermethylation with early recurrence in superficial bladder cancers. Cancer Res 2002; 62: 4048–53.
Sidransky D, Von Eschenbach A, Tsai YC, Jones P, Summerhayes I, Marshall F . Identification of p53 gene mutations in bladder cancers and urine samples. Science 1991; 252: 706–9.
Parmar MK, Freedman LS, Hargreave TB, Tolley DA . Prognostic factors for recurrence and followup polices in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). J Urol 1989; 142 ( 2 Pt 1): 284–8.
Morris SB, Gordon EM, Shearer RJ, Woodhouse CR . Superficial bladder cancer: for how long should a tumor-free patient have check cystoscopies? Br J Urol 1995; 75: 193–6.
Millan-Rodriguez F, Chechile-Toniolo G, Salvador-Bayarri J, Palou J, Algaba F . Primary Superficial bladder cancer risk groups according to progression, mortality and recurrence. J Urol 2000; 164: 680–4.
Inouye CJ, Seto E . Relief of YY1-induced transcriptional repression by protein-protein interaction with the nucleolar phosphoprotein B23. J Biol Chem 1994; 269: 6506–10.
Valdez BC, Perlaky L, Henning D, Saijo Y, Chan PK, Busch H . Identification of the nuclear and nucleolar localization signals of the protein p120: interaction with translocation protein B23. J Biol Chem 1994; 269: 23 776–83.
Kondo T, Minamino N, Nagamura-Inoue T, Matsumoto M, Taniguchi T, Tanaka N . Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity. Oncogene 1997; 15: 1275–81.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by Chang Gung Memorial Hospital (Grant No CMRPD1003-III, CMRPD32015, and CMRPG331193) and the National Science Council of Taiwan, China (Grant No NSC94-2745-B-182-001-URD, NSC94-2320-B-182-009, and NSC 96-2314-B-182A-016-MY2).
Rights and permissions
About this article
Cite this article
Tsui, Kh., Juang, Hh., Lee, Th. et al. Association of nucleophosmin/B23 with bladder cancer recurrence based on immunohistochemical assessment in clinical samples. Acta Pharmacol Sin 29, 364–370 (2008). https://doi.org/10.1111/j.1745-7254.2008.00747.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2008.00747.x
Keywords
This article is cited by
-
NPM1 as a potential therapeutic target for atypical teratoid/rhabdoid tumors
BMC Cancer (2019)
-
NPM1 alternative transcripts are upregulated in acute myeloid and lymphoblastic leukemia and their expression level affects patient outcome
Journal of Translational Medicine (2018)
-
Increased nucleophosmin expression is a strong predictor of recurrence and prognosis in patients with N0M0 upper tract urothelial carcinoma undergoing radical nephroureterectomy
World Journal of Urology (2017)
-
Nucleophosmin1 associated with drug resistance and recurrence of bladder cancer
Clinical and Experimental Medicine (2015)
-
Expression of B23/Nucleophosphamine Nonribosomal Nucleolar Protein in Smooth Muscle Tumors of the Corpus Uteri
Bulletin of Experimental Biology and Medicine (2015)